A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2026 ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Screening rules are too narrow and keep patients from receiving care until it’s too late, say many Boston-area researchers ...

Researchers developed and validated a new lung cancer prediction model, Sybil-Epi, by integrating clinical and epidemiologic data with a pre-existing model.

Some level of the odourless, colourless radioactive gas is in every home — but long-term overexposure is considered a Class 1 ...

The new Cancer Doesn't Care Fund, founded by the American College of Radiology Foundation and the Cancer Doesn't Care initiative, will fuel efforts to expand screening access, boost early detection ...

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...

Denmark: A recent exploratory analysis published in Clinical Obesity has found that liraglutide, a GLP-1 receptor agonist ...

Researchers at Mount Sinai have created an analytic tool using machine learning that they say can predict cardiovascular disease risk in millions of patients with obstructive sleep apnea, according to ...

New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...